Skip to main content
Erschienen in: Archives of Virology 3/2018

05.12.2017 | Brief Report

A comparison of the MeltPro® HPV Test with the Cobas® HPV Test for detecting and genotyping 14 high-risk human papillomavirus types

verfasst von: Zhiteng Tang, Ye Xu, Najie Song, Dongqing Zou, Yiqun Liao, Qingge Li, Chao Pan

Erschienen in: Archives of Virology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

The clinical performance of the newly developed MeltPro® HPV Test, based on multicolor melting curve analysis, was evaluated and compared with the commercially available Cobas® HPV Test for detection of HPV and genotyping of HPV-16 and HPV-18. A total of 1647 cervical samples were analyzed with both tests. The agreement values were 96.2% for HPV detection, 99.6% for HPV-16 identification, and 99.7% for HPV-18 identification. All genotyping results from MeltPro® HPV Test showed that HPV-52, HPV-58, and HPV-16 were the most common types in this study. Intra-laboratory reproducibility studies showed 97.8% agreement while inter-laboratory reproducibility studies showed 96.9% agreement for the MeltPro® HPV Test. The MeltPro® HPV Test and Cobas® HPV Test are highly correlative and are useful for monitoring HPV infection.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Woodman CBJ, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7:11–22CrossRefPubMed Woodman CBJ, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7:11–22CrossRefPubMed
2.
Zurück zum Zitat Henry CK, Maribel A, Claire T, Paula W, Alexandra S, Boyka S, Clare G, Helene B, Christopher R, Robin D, Mina D, Jean M, Andrew B, Andrew T, Sue M, Julian P (2009) HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomized controlled trial. Lancet Oncol 10:672–682CrossRef Henry CK, Maribel A, Claire T, Paula W, Alexandra S, Boyka S, Clare G, Helene B, Christopher R, Robin D, Mina D, Jean M, Andrew B, Andrew T, Sue M, Julian P (2009) HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomized controlled trial. Lancet Oncol 10:672–682CrossRef
3.
Zurück zum Zitat World Health Organization (2010) Human papillomavirus laboratory manua. Section 5:35–63 World Health Organization (2010) Human papillomavirus laboratory manua. Section 5:35–63
5.
Zurück zum Zitat Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348:518–527CrossRefPubMed Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348:518–527CrossRefPubMed
6.
Zurück zum Zitat Lörincz AT (1996) Hybrid Capture™ method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 22:629–636CrossRefPubMed Lörincz AT (1996) Hybrid Capture™ method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 22:629–636CrossRefPubMed
7.
Zurück zum Zitat Gravitt P, Peyton C, Apple R, Wheeler C (1998) Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a singlehybridization, reverse line blot detection method. J. Clin. Microbiol 36:3020–3027PubMedPubMedCentral Gravitt P, Peyton C, Apple R, Wheeler C (1998) Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a singlehybridization, reverse line blot detection method. J. Clin. Microbiol 36:3020–3027PubMedPubMedCentral
8.
Zurück zum Zitat Kleter B, Van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, Ter Schegget J, Lindeman J, Harmsel BT, Burger M, Quint W (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37:2508–2517PubMedPubMedCentral Kleter B, Van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, Ter Schegget J, Lindeman J, Harmsel BT, Burger M, Quint W (1999) Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37:2508–2517PubMedPubMedCentral
9.
Zurück zum Zitat Liu SS, Leung RCY, Chan KKL, Cheung ANY, Ngan HYS (2010) Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche linear array HPV genotyping assay. J Clin Microbiol 48:758–764CrossRefPubMed Liu SS, Leung RCY, Chan KKL, Cheung ANY, Ngan HYS (2010) Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche linear array HPV genotyping assay. J Clin Microbiol 48:758–764CrossRefPubMed
10.
Zurück zum Zitat Heideman D, Hesselink A, Berkhof J, van Kemenade F, Melchers W, Daalmeijer NF, Verkuijten M, Meijer CJLM, Snijders PJF (2011) Clinical validation of the Cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol 49:3983–3985CrossRefPubMedPubMedCentral Heideman D, Hesselink A, Berkhof J, van Kemenade F, Melchers W, Daalmeijer NF, Verkuijten M, Meijer CJLM, Snijders PJF (2011) Clinical validation of the Cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol 49:3983–3985CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Cuzick J, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, Bergeron C, Soutter WP, Lyons D, Szarewski A (2010) Performance of the Abbott real time high-risk HPV test in women with abnormal cervical cytology smears. J Med Virol 82:1186–1191CrossRefPubMed Cuzick J, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, Bergeron C, Soutter WP, Lyons D, Szarewski A (2010) Performance of the Abbott real time high-risk HPV test in women with abnormal cervical cytology smears. J Med Virol 82:1186–1191CrossRefPubMed
12.
Zurück zum Zitat Hwang Y, Lee M (2012) Comparison of the AdvanSure human papillomavirus screening real-time PCR, the Abbott real time high risk human papillomavirus test, and the hybrid capture human papillomavirus DNA test for the detection of human papillomavirus. Ann Lab Med 32:201–205CrossRefPubMedPubMedCentral Hwang Y, Lee M (2012) Comparison of the AdvanSure human papillomavirus screening real-time PCR, the Abbott real time high risk human papillomavirus test, and the hybrid capture human papillomavirus DNA test for the detection of human papillomavirus. Ann Lab Med 32:201–205CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Micalessi IM, Boulet GA, Bogers JJ, Benoy IH, Depuydt CE (2012) High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin Chem Lab Med 50:655–661CrossRef Micalessi IM, Boulet GA, Bogers JJ, Benoy IH, Depuydt CE (2012) High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR. Clin Chem Lab Med 50:655–661CrossRef
14.
Zurück zum Zitat Liao Y, Zhou Y, Guo Q, Xie X, Luo E, Li J, Li Q (2013) Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis. J Clin Microbiol 51:429–435CrossRefPubMedPubMedCentral Liao Y, Zhou Y, Guo Q, Xie X, Luo E, Li J, Li Q (2013) Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis. J Clin Microbiol 51:429–435CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Arbyn M, Depuydt C, Benoy I, Bogers J, Cuschieri K, Schmitt M, Pawlita M, Geraets D, Heard I, Gheit T, Tommasino M, Poljak M, Bonde J, Quint W (2016) VALGENT: a protocol for clinical validation of human papillomavirus assays. J Clin Virol 76:S14–S21CrossRefPubMed Arbyn M, Depuydt C, Benoy I, Bogers J, Cuschieri K, Schmitt M, Pawlita M, Geraets D, Heard I, Gheit T, Tommasino M, Poljak M, Bonde J, Quint W (2016) VALGENT: a protocol for clinical validation of human papillomavirus assays. J Clin Virol 76:S14–S21CrossRefPubMed
16.
Zurück zum Zitat Geraets DT, Cuschieri K, de Koning MN, van Doorn LJ, Snijders PJ, Meijer CJ, Quint WG, Arbyn M (2014) Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control. J Clin Microbiol 52:3996–4002CrossRefPubMedPubMedCentral Geraets DT, Cuschieri K, de Koning MN, van Doorn LJ, Snijders PJ, Meijer CJ, Quint WG, Arbyn M (2014) Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control. J Clin Microbiol 52:3996–4002CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Cuschieri K, Geraets DT, Moore C, Quint W, Duvall E, Arbyn M (2015) Clinical and analytical performance of the Onclarity HPV assay using the VALGENT framework. J Clin Microbiol 53:3272–3279CrossRefPubMedPubMedCentral Cuschieri K, Geraets DT, Moore C, Quint W, Duvall E, Arbyn M (2015) Clinical and analytical performance of the Onclarity HPV assay using the VALGENT framework. J Clin Microbiol 53:3272–3279CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Heard I, Cuschieri K, Geraets DT, Quint W, Arbyn M (2016) Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework. J Clin Virol 81:6–11CrossRefPubMed Heard I, Cuschieri K, Geraets DT, Quint W, Arbyn M (2016) Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework. J Clin Virol 81:6–11CrossRefPubMed
19.
Zurück zum Zitat Shixuan H, Irina A, Beth AM, Anna MB (1997) Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70:408–411CrossRef Shixuan H, Irina A, Beth AM, Anna MB (1997) Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 70:408–411CrossRef
20.
Zurück zum Zitat Shuang L, Xiao C, Min L, Fengxia C, Liang M, Yongtong C (2015) Distribution of high-risk human papillomavirus genotypes in HPV-infected women in Beijing, China. J Med Virol 87:504–507CrossRef Shuang L, Xiao C, Min L, Fengxia C, Liang M, Yongtong C (2015) Distribution of high-risk human papillomavirus genotypes in HPV-infected women in Beijing, China. J Med Virol 87:504–507CrossRef
Metadaten
Titel
A comparison of the MeltPro® HPV Test with the Cobas® HPV Test for detecting and genotyping 14 high-risk human papillomavirus types
verfasst von
Zhiteng Tang
Ye Xu
Najie Song
Dongqing Zou
Yiqun Liao
Qingge Li
Chao Pan
Publikationsdatum
05.12.2017
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 3/2018
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3645-1

Weitere Artikel der Ausgabe 3/2018

Archives of Virology 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.